## Adjunctive Therapy in Fluctuating Parkinson's Disease ### Recommended Adjuncts (Options 0, 1, 3) **Option 0 — Pramipexole:** **Key Point:** Pramipexole is a non-ergot dopamine agonist (preferential D2/D3 agonist) approved as an adjunct to levodopa in fluctuating PD. It extends the duration of motor response and reduces off-time. **Option 1 — Amantadine:** **High-Yield:** Amantadine is an NMDA receptor antagonist with unique benefits in advanced PD: - Reduces levodopa-induced dyskinesias (LID) by 30–50% - Reduces off-time and improves motor function - Mechanism: blocks glutamatergic excitotoxicity in the striatum - One of the few agents that **reduces dyskinesias** rather than worsening them **Clinical Pearl:** Amantadine is particularly valuable in patients with troublesome dyskinesias despite dose optimization. **Option 3 — Rasagiline:** **Key Point:** Rasagiline is a selective, irreversible MAO-B inhibitor (more potent than selegiline). As an adjunct to levodopa, it: - Prolongs dopamine half-life - Reduces off-time and motor fluctuations - Approved for both early and advanced PD ### NOT Recommended (Option 2 — The Answer) **Warning:** Anticholinergics are **contraindicated or strongly discouraged** in advanced Parkinson's disease with motor fluctuations. **High-Yield:** Trihexyphenidyl and other anticholinergics: 1. **Worsen cognitive function** — high risk of dementia, confusion, hallucinations in older patients 2. **Increase dyskinesias** — paradoxically worsen motor complications in advanced PD 3. **Limited efficacy in advanced disease** — tremor and rigidity are no longer the dominant features; bradykinesia and fluctuations dominate 4. **Autonomic side effects** — urinary retention, constipation, dry mouth 5. **Narrow therapeutic window** — toxicity risk outweighs benefit in fluctuating PD **Mnemonic:** **ACME** — Anticholinergics Cause Motor complications and cognitive Encephalopathy in advanced PD. **Clinical Pearl:** Anticholinergics may have a limited role in **early, tremor-dominant PD** in younger patients, but are avoided in advanced disease, especially with fluctuations or cognitive decline. ### Summary Table: Adjuncts in Fluctuating PD | Agent | Class | Mechanism | Benefit | Caution | | --- | --- | --- | --- | --- | | Pramipexole | Dopamine agonist | D2/D3 agonism | Extends motor response | Impulse control disorders | | Amantadine | NMDA antagonist | Blocks glutamate excitotoxicity | **Reduces dyskinesias** | Renal clearance, livedo reticularis | | Rasagiline | MAO-B inhibitor | Prolongs dopamine half-life | Reduces off-time | Hypertensive crisis with tyramine | | **Trihexyphenidyl** | **Anticholinergic** | **Blocks acetylcholine** | **Tremor (early PD only)** | **Worsens fluctuations, cognition** |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.